Nichino America Inc v. Valent USA LLC ( 2022 )


Menu:
  •                                       PRECEDENTIAL
    UNITED STATES COURT OF APPEALS
    FOR THE THIRD CIRCUIT
    ______________
    No. 21-1850
    ______________
    NICHINO AMERICA, INC.,
    Appellant
    v.
    VALENT U.S.A. LLC
    ______________
    On Appeal from the United States District Court for the
    District of Delaware
    (D.C. No. 1-20-cv-00704)
    District Judge: Honorable Leonard P. Stark
    ______________
    Argued March 22, 2022
    Before: BIBAS, MATEY, and PHIPPS, Circuit Judges
    (Filed: August 12, 2022)
    Bradley L. Cohn [Argued]
    Jacquelyn Prom
    Belinda J. Scrimenti
    Pattishall McAuliffe Newbury Hilliard & Geraldson
    200 South Wacker Drive
    Suite 2900
    Chicago, IL 60606
    Counsel for Appellee
    Eric R. Clendening
    Flaster Greenberg
    1810 Chapel Avenue West
    Cherry Hill, NJ 08002
    Jordan A. LaVine [Argued]
    Flaster Greenberg
    Suite 1050
    1717 Arch Street
    Suite 3300
    Philadelphia, PA 19103
    Counsel for Appellant
    ______________
    OPINION OF THE COURT
    ______________
    MATEY, Circuit Judge.
    Whether a federal court may issue an injunction against
    an allegedly infringing trademark can be a bit confusing.
    Responding, Congress passed the Trademark Modernization
    2
    Act of 2020 (“TMA”).1 Nichino America Inc. says the District
    Court misapplied the TMA when it denied its motion for a
    preliminary injunction against Valent USA LLC’s allegedly
    infringing mark. Finding no reversible error in the District
    Court’s careful application of its discretion, we will affirm.
    Along the way, we explain how district courts should apply the
    rebuttable presumption of irreparable harm created by the
    TMA.
    I.
    A.    The Marks
    Nichino and Valent sell pesticides for farming. Since
    2004, Nichino has offered a trademarked product known as
    “CENTAUR.” Valent trademarked a competing product called
    “SENSTAR” in 2019, giving it a logo resembling
    CENTAUR’s colors, fonts, and arrow artwork. Both pesticides
    are used in the same geographic areas against many of the same
    insects, and both are sold to farmers through distributors. But
    there are differences. SENSTAR comes as a liquid and uses a
    unique combination of two active chemicals. It costs $425 per
    gallon, and ships in cases containing four one-gallon
    containers. CENTAUR is manufactured as a solid and sold by
    the pallet, with each containing 622 pounds of pesticide packed
    into bags and cases, for $24 per pound. Yet the similarities
    were enough for Nichino to sue Valent for trademark
    infringement, and ask for a preliminary injunction against
    SENSTAR’s launch. A suit that would become one of the first
    to apply the newly effective TMA.
    1
    Pub. L. No. 116-260, H.R. 133, 116th Cong. subtit. B,
    §§ 221–26 (2020).
    3
    B.     District Court Proceedings
    Nichino argued that Valent’s use of the SENSTAR
    mark would create confusion among consumers, a necessary
    element in a trademark infringement claim. See A & H
    Sportswear, Inc. v. Victoria’s Secret Stores, Inc., 
    237 F.3d 198
    ,
    210 (3d Cir. 2000). Confusion, said Nichino, likely to harm its
    reputation and goodwill, warranting injunctive relief.2 That is
    where the TMA enters, creating a rebuttable presumption of
    irreparable harm favoring a plaintiff who has shown a
    likelihood of success on the merits of an infringement claim.3
    The District Court found Nichino narrowly
    demonstrated its infringement claim would likely succeed,
    though “there is not an abundance of evidence of likelihood of
    confusion” between the products. (App. at 176.) The District
    Court reached that conclusion by consulting the “Lapp
    factors,” our nearly forty-year-old, ten-part, yet non-exhaustive
    inquiry that guides analysis of likely confusion. See Interpace
    2
    Injunctions require the familiar showing of a
    likelihood of success on the merits, irreparable harm that
    outweighs the burden on the nonmoving party, and benefit to
    the public interest. Kos Pharms., Inc. v. Andrx Corp., 
    369 F.3d 700
    , 708 (3d Cir. 2004). These burdens are all borne by
    Nichino. Ferring Pharms., Inc. v. Watson Pharms., Inc., 
    765 F.3d 205
    , 210 (3d Cir. 2014).
    3
    In relevant part, the TMA states that plaintiffs seeking
    an injunction “shall be entitled to a rebuttable presumption of
    irreparable harm . . . upon a finding of likelihood of success on
    the merits for a violation identified in this subsection in the
    case of a motion for a preliminary injunction or temporary
    restraining order.” Pub. L. No. 116-260 § 226(a).
    4
    Corp. v. Lapp, Inc., 
    721 F.2d 460
    , 462–63 (3d Cir. 1983); see
    also A & H Sportswear, Inc., 
    237 F.3d at 213
     (prescribing use
    of the Lapp factors in all trademark cases).4 Weighing and
    balancing, the District Court tallied a final score of five factors
    favoring Nichino, two neutral, and three “very important
    factors” (overall degree of similarity, consumers’ purchasing
    habits, and Valent’s intent in selecting the mark) in Valent’s
    column. (App. at 161–76.) Bringing us to the TMA, which the
    District Court applied to presume Nichino would suffer
    irreparable harm without an injunction. But that presumption
    is rebuttable, and the District Court credited Valent’s evidence
    of a sophisticated consumer class that makes careful purchases,
    and noted the lack of any evidence of actual consumer
    confusion. Closing the circle, the District Court found Nichino
    failed to proffer evidence that it would likely suffer irreparable
    4
    The factors summarized in Lapp break into three
    categories. First, facts about the plaintiff’s mark, including its
    distinctiveness. Second, facts about the defendant’s actions,
    including whether the mark was adopted to intentionally
    compete, overlapping sales and marketing efforts, and how
    long the competing mark has been in the market without
    confusion. Third, facts about how consumers deal with both
    marks. Is there evidence of actual confusion, or do costs and
    other differences between the goods make confusion unlikely?
    See Lapp, 
    721 F.2d at
    463–64 (holding that trial court
    adequately addressed “every relevant area of inquiry” without
    “formally apply[ing]” the factors when it made findings about
    “[t]he plaintiff’s mark,” how “the defendant markets its
    products,” and “[f]inally and perhaps most important,” what
    “customers in the [relevant] field would find [] natural or
    likely” about which company makes which product).
    5
    harm without immediate injunctive relief.5 Finally, the District
    Court held that the balance of equities and public interest weigh
    against issuing a preliminary injunction.
    For those reasons, the District Court denied the
    injunction, and Nichino appealed, challenging the Court’s
    finding that Valent had rebutted the presumption of irreparable
    harm.6 Finding no reversible error that disturbs the District
    Court’s conclusion, we will affirm.7
    II.
    Nichino contends that the TMA precluded the District
    Court’s decision about irreparable harm. But the District Court
    admirably navigated Congress’ newly minted rebuttable
    presumption. While our discussion builds on the District
    Court’s insights, we arrive at the same conclusion. Valent
    5
    Here, the District Court appropriately cited Nichino’s
    evidence of likely consumer confusion. Evidence of consumer
    confusion is relevant to both likelihood of success and
    irreparable harm, so the evidence that plaintiffs offer to show
    one will often also tend to show the other. See Kos Pharms.,
    Inc., 
    369 F.3d at 726
     (highlighting the importance of consumer
    confusion to both inquiries).
    6
    The District Court had jurisdiction under 
    28 U.S.C. §§ 1331
     and 1338(a), and we have jurisdiction under 
    28 U.S.C. § 1292
    (a)(1).
    7
    We review the District Court’s factual findings for
    clear error, the legal conclusions de novo, and the decision
    whether to grant an injunction for abuse of discretion. Osorio-
    Martinez v. Att’y Gen., 
    893 F.3d 153
    , 161 (3d Cir. 2018).
    6
    rebutted the presumption, and Nichino did not independently
    show irreparable harm.
    A.     Federal Rule of Evidence 301 Grounds the TMA
    Like all laws, the TMA does not exist in isolation. It
    complements existing rules and standards and is informed by
    their established effect. One complement, Federal Rule of
    Evidence 301, aids our understanding of the best ordinary
    meaning of the TMA.8 Rule 301 provides that, in all civil cases,
    absent specific statutory language to the contrary, “the party
    against whom a presumption is directed has the burden of
    producing evidence to rebut the presumption.” Fed. R. Evid.
    301. That allocation “does not shift the burden of persuasion,
    which remains on the party who had it originally.” Id.9 That
    8
    Because Congress gave Federal Rules promulgated
    under the Rules Enabling Act, 
    28 U.S.C. § 2072
    , the status of
    laws of the United States, see Shady Grove Orthopedic
    Assocs., P.A. v. Allstate Ins. Co., 
    559 U.S. 393
    , 398, 399
    (2010), we interpret such Rules using the traditional tools of
    statutory interpretation to discover their ordinary meaning. See,
    e.g., UGI Sunbury LLC v. A Permanent Easement for 1.7575
    Acres, 
    949 F.3d 825
    , 832–33 (3d Cir. 2020) (interpreting
    Federal Rule of Evidence 702 according to its text); see also
    United States v. Melvin, 
    948 F.3d 848
    , 852 (7th Cir. 2020)
    (explaining that courts interpret the Federal Rules using the
    “words’ ordinary, contemporary, common meaning by looking
    at what they meant when . . . enacted”) (citing Pavelic &
    LeFlore v. Marvel Entm’t Grp., 
    493 U.S. 120
    , 123 (1989)).
    9
    The burden of production, Professor Wigmore
    explained, is the obligation “to come forward with . . . some
    evidence . . . sufficient” to show that disputed issues of fact
    7
    framework applies here because the TMA creates a rebuttable
    presumption without explaining how it applies. Lupyan v.
    Corinthian Colls. Inc., 
    761 F.3d 314
    , 320 (3d Cir. 2014)
    (“Federal Rule [of] Evidence 301 provides the default rule for
    how presumptions operate in federal civil cases.”); Cappuccio
    v. Prime Cap. Funding LLC, 
    649 F.3d 180
    , 190 (3d Cir. 2011)
    (applying Rule 301 to the Truth in Lending Act, 15 U.S.C
    § 1601 et seq., after finding “no language . . . to create a
    stronger presumption”).
    Because Rule 301 shifts the evidentiary burden of
    production, but leaves the burden of persuasion unmoved, the
    task of courts applying the TMA is limited. Over-scrutinizing
    the persuasive value of evidence proffered on rebuttal would
    violate Rule 301 by shifting the burden of persuasion, not just
    the burden of production. See Cappuccio, 
    649 F.3d at 189
    .
    Instead, courts must ask only whether the rebuttal evidence is
    exist. John Henry Wigmore, Wigmore on Evidence: Evidence
    in Trials at Common Law § 2491 (4th ed. 1985). Satisfying that
    burden shifts “the same duty [to] the other party,” who must
    produce evidence on the other side of the issue. Id. § 2493.
    Throughout this shifting one thing never changes: the burden
    of persuasion, meaning the obligation to convince the fact-
    finder on the issue, always remains with the same party. Id.;
    see also McCann, 458 F.3d at 287 (“There are two distinct
    elements . . . the burden of going forward with proof (the
    burden of ‘production’) and the burden of persuading the trier
    of fact (the burden of ‘persuasion’).”) (cleaned up); St. Mary’s
    Honor Ctr. v. Hicks, 
    509 U.S. 502
    , 507 (1993) (a Rule 301
    “presumption shifts the burden of production to the defendant,
    [but] the ultimate burden of persuading the trier of fact . . .
    remains at all times with the plaintiff”) (cleaned up).
    8
    enough to allow a reasonable factfinder to conclude that
    irreparable harm is unlikely.10 With that guidance in hand, we
    sketch the steps for applying the TMA’s rebuttable
    presumption.
    Step 1.       The TMA’s rebuttable presumption
    requires courts considering a trademark injunction to assess the
    plaintiff’s evidence only as it relates to a likelihood of success
    on the merits. Consulting the Lapp factors to analyze
    likelihood of confusion, but only to determine whether the
    infringement claim is likely to succeed. Anything more,
    including commenting on whether the proffered evidence of
    consumer confusion could show irreparable harm, veers
    impermissibly into the burden of persuasion controlled by Rule
    301. If a court finds no likelihood of success on the merits, the
    inquiry ends and the injunction will be denied. See, e.g., Kos
    Pharms., Inc., 
    369 F.3d at 709
    ; NutraSweet Co. v. Vit-Mar
    Enters, Inc., 
    176 F.3d 151
    , 153 (3d Cir. 1999) (“A plaintiff’s
    failure to establish any element in its favor renders a
    preliminary injunction inappropriate.”).
    10
    That small quantum of evidence is all we have
    required to rebut Rule 301 presumptions. In Cappuccio, we
    held that a borrower’s own testimony that her lender had not
    properly explained the right to cancel her home mortgage was
    enough to rebut the Truth in Lending Act’s presumption that
    notice was received. 
    649 F.3d at
    189–90. We held that such
    meager evidence as “a single, non-conclusory affidavit . . .
    based on personal knowledge” is enough “even if the affidavit
    is ‘self-serving.’” 
    Id.
     And in McCann, we applied the same
    standard to rebuttals of the common-law presumption in favor
    of established domicile, rejecting a more demanding “clear and
    convincing evidence” rebuttal standard. 458 F.3d at 287–88.
    9
    Step 2.        If the plaintiff’s evidence does establish
    likely trademark infringement, the TMA is triggered, and the
    burden of production shifts to the defendant to introduce
    evidence sufficient for a reasonable factfinder to conclude that
    the consumer confusion is unlikely to cause irreparable harm.
    See Cappuccio, 
    649 F.3d at 189
    . But note again the sequence.
    So far, the court has not assessed any of the evidence for likely
    irreparable harm. Rather, the TMA’s presumption means the
    court assumes irreparable harm, even if the plaintiff has
    proffered nothing in support. The focus trains on the
    defendant’s evidence, and whether it is sufficient to rebut the
    TMA’s presumption. A meaningful consideration of the facts,
    not a box-checking review of the Lapp factors, is key, aimed at
    determining whether the defendant’s offering allows a
    reasonable conclusion that the consumer confusion shown by
    the plaintiff will not cause irreparable harm.
    Step 3.       If a defendant successfully rebuts the
    TMA’s presumption by making this slight evidentiary
    showing, the presumption has no further effect. It has done its
    work and simply disappears like a bursting bubble. See
    McCann v. Newman Irrevocable Trust, 
    458 F.3d 281
    , 287–88
    (3d Cir. 2006). So the burden of production returns to the
    plaintiff to point to evidence that irreparable harm is likely
    absent an injunction. See 
    id.
     (“Under Fed. R. Evid. 301 . . . the
    introduction of evidence to rebut a presumption destroys that
    presumption, leaving only that evidence and its inferences to
    be judged against the competing evidence and its inferences to
    determine the ultimate question at issue.” (quoting McKenna
    v. Pac. Rail Serv., 
    32 F.3d 820
    , 830 (3d Cir. 1994))). Here
    again, the evaluation outlined in Lapp may prove useful to
    10
    assess whether consumer confusion will lead to irreparable
    harm.11
    B.     The District Court’s Rebuttal Analysis Follows Rule
    301
    The District Court’s finding that Valent rebutted the
    TMA’s presumption follows the TMA and tracks Rule 301.
    The District Court began by using the Lapp factors to assess
    likelihood of consumer confusion to determine Nichino’s
    likelihood of success on the merits without simultaneously
    considering irreparable harm.12 Finding that Nichino would
    likely succeed on the merits, the District Court properly
    applied the TMA by presuming irreparable harm and turning
    its attention to Valent’s rebuttal evidence. Here, the District
    11
    Contrary to Nichino’s argument, § 226(b) of the TMA
    does not fight this reading. A “Rule of Construction,” § 226(b)
    states the Act “shall not be construed to mean that a plaintiff
    seeking an injunction was not entitled to a presumption of
    irreparable harm before the date of enactment of this Act.” Pub.
    L. No. 116-260 § 226(b). Read in context, that means a
    plaintiff is always entitled to the newly codified presumption,
    even if the infringing conduct predated the TMA. Nichino
    enjoyed that benefit here.
    12
    Nichino contests the District Court’s finding that the
    degree of similarity between the marks favored Valent, but that
    is not clearly erroneous. The District Court found that the
    auditory similarity of the marks’ pronunciations favored
    Nichino, while the marks’ visual dissimilarities leaned toward
    Valent. And the Court found appearance more important than
    sound. All questions of fact best weighed by the District Court,
    and we have no occasion to disturb that conclusion.
    11
    Court again appropriately referenced the Lapp factors for
    consumer confusion, described them as “closely balanced,”
    and found that Valent had rebutted the presumption by
    producing evidence of a sophisticated consumer class. (App. at
    177–80.) A framework that anticipated the steps we provide
    today.
    Nichino is correct that the District Court erred by
    considering Nichino’s failure to produce evidence of actual
    confusion at this stage, when the sole focus is whether Valent
    had adduced affirmative evidence that irreparable harm is
    unlikely. As explained, the TMA shifted the burden of
    production to Valent when Nichino showed likely success.
    And Valent cannot meet that production burden simply by
    pointing to Nichino’s lack of evidence. Faulting Nichino
    improperly placed the burden of production on the plaintiff at
    the rebuttal stage.
    But that slight error does not undermine the District
    Court’s judgment. The Court also credited Valent’s evidence
    that the relevant consumers are sophisticated buyers who
    exercise great care in purchasing pesticides. Among the facts
    noted by the Court: 1) the differing prices; 2) the expense of
    seasonal treatment; 3) regular reliance on expert
    recommendations; and 4) the consequences of misapplication,
    including crop destruction and corresponding disastrous
    economic consequences. All tending to heighten purchasing
    care, and all making it plausible to conclude that consumers
    will confirm their pesticide selection before staking their farms
    on an inadvertent purchase. As the District Court correctly
    held, this evidence meets the light burden of production that
    12
    the TMA’s presumption of irreparable harm placed on
    Valent.13
    With the presumption rebutted, the burden of evidence
    production returned to Nichino to show likely irreparable harm
    absent an injunction. The District Court found that Nichino did
    not, and Nichino does not argue otherwise. That makes the
    District Court’s conclusion, and its decision to deny injunctive
    relief, correct, as “[a] plaintiff’s failure to establish any element
    in its favor renders a preliminary injunction inappropriate.”
    NutraSweet Co., 
    176 F.3d at 153
    .14
    13
    Nichino is right that “the standard of care [in
    purchasing] . . . will be equal to that of the least sophisticated
    consumer in the class,” Ford Motor Co. v. Summit Motor
    Prods., 
    930 F.2d 277
    , 293 (3d Cir. 1991), but that is the
    standard that the District Court used by focusing on small
    commercial farmers, not large agribusiness operations. Nor
    does the sophistication of the farm workers applying the
    chemicals much matter, because they do not make the
    purchasing decisions, and we evaluate the sophistication of the
    “buyer class,” not the broader class of all users. 
    Id.
    14
    While unnecessary to our decision, we see no error in
    the District Court’s balancing of equities. Ample evidence
    supports the Court’s conclusion that an injunction would cause
    Valent to lose significant sales while it reapplied, and awaited
    approval, for a new trademark. Those amounts, using Valent’s
    pre-release projections, measured in millions of lost dollars.
    (See S. App. at 445.) Nor is there error in the Court’s finding
    that the public interest “is better served by allowing continued
    access to an innovative product[, SENSTAR,] that can be used
    against all insect life stages.” (App. at 181.)
    13
    III.
    For these reasons, we will affirm the District Court’s
    order denying Nichino’s motion for a preliminary injunction.
    14